9783764364595 - Mechanisms of Angiogenesis: 94 (Experientia Supplementum, 94) (17 resultados)

2005th ed. 17 x 24 cm. 338 pages. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Hardcover. Condición: New. In shrink wrap. Looks like an interesting title!

Hardcover. Condición: New. In shrink wrap. Looks like an interesting title!

Condición: New. pp. 340.

Condición: New. pp. 340 Illus.

Condición: Sehr gut. Zustand: Sehr gut | Seiten: 340 | Sprache: Englisch | Produktart: Bücher | Is it advisable to go back from bedside to the bench? During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy.

Condición: New. pp. 340.

Condición: New. In.

Condición: New. The induction of blood vessel growth can be either exaggerated, such as in tumors, or too slow, as in ischemic diseases of heart and brain. This volume looks at our knowledge of factors and principles involved in angiogenic processes, proceeding from a "macroscopic " perspective through cellular and physical mechanisms to the molecular level. Editor(s): Clauss, Matthias; Breier, Georg. Series: Experientia Supplementum. Num Pages: 338 pages, biography. BIC Classification: MFG; MJD. Category: (G) General (US: Trade); (P) Professional & Vocational. Dimension: 244 x 170 x 23. Weight in Grams: 765. . 2004. Hardback. . . . .

Hardcover. Condición: Like New. Like New. book.

Gebunden. Condición: New. A concise compilation of current knowledge on angiogenesisPresents new targets for medical interventionProvides insight into molecular mechanisms of blood vessel growthIs it advisable to go back from bedside to the bench? During the.

Hardcover. Condición: Brand New. 1st edition. 307 pages. German language. 9.00x6.75x0.75 inches. In Stock.

Condición: New. The induction of blood vessel growth can be either exaggerated, such as in tumors, or too slow, as in ischemic diseases of heart and brain. This volume looks at our knowledge of factors and principles involved in angiogenic processes, proceeding from a "macroscopic " perspective through cellular and physical mechanisms to the molecular level. Editor(s): Clauss, Matthias; Breier, Georg. Series: Experientia Supplementum. Num Pages: 338 pages, biography. BIC Classification: MFG; MJD. Category: (G) General (US: Trade); (P) Professional & Vocational. Dimension: 244 x 170 x 23. Weight in Grams: 765. . 2004. Hardback. . . . . Books ship from the US and Ireland.

Condición: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Buch. Condición: Neu. Neuware - Is it advisable to go back from bedside to the bench During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy.